Anzeige
Meldung des Tages: China kartiert den Meeresboden. Das Pentagon fordert Nickel. Ein Unternehmen mit 27 Mio. CAD Bewertung hat soeben reagiert.

Novocure News

Aktie
WKN:  A140ML ISIN:  JE00BYSS4X48 US-Symbol:  NVCR Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Schweiz
12,835 $
+0,215 $
+1,70%
10,911 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
1,24 Mrd. €
Streubesitz
6,52%
KGV
-19,10
Index-Zuordnung
-

Novocure News

01.04.26 - Businesswire
Novocure to Report First Quarter 2026 Financial Results
Novocure (NASDAQ: NVCR) will report financial results for the first quarter 2026 on April 30, 2026, before the U.S. financial markets open.
26.03.26 - Businesswire
Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
Novocure (NASDAQ: NVCR) announced positive results today from the Phase 2 PANOVA-4 trial of Tumor Treating Fields (TTFields) therapy concomitant with atezolizumab (Tecentriq ...
02.03.26 - Businesswire
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare approved reimbursement for Optune Lua ® through the country’s National Health ...
25.02.26 - PR Newswire
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
Immuno-​Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire
24.02.26 - Businesswire
Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)
Novocure (NASDAQ: NVCR) announced today that the province of British Columbia, Canada, will now cover Tumor Treating Fields (TTFields) therapy for the treatment of adult ...
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
11.02.26 - Businesswire
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax ® for the treatment of adult patients with locally advanced ...

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »